Fidelity Disruptive Medicine ETF (FMED) Short Interest Ratio & Short Volume

Short interest is the volume of Fidelity Disruptive Medicine ETF shares that have been sold short but have not yet been covered or closed out. As of July 15th, traders have sold 900 shares of FMED short. Learn More on Fidelity Disruptive Medicine ETF's current short interest.

Fidelity Disruptive Medicine ETF saw a increase in short interest in the month of July. As of July 15th, there was short interest totaling 900 shares, an increase of 125.0% from the previous total of 400 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies compare to Fidelity Disruptive Medicine ETF: Siren Nasdaq NexGen Economy ETF (2.10%), Tema Heart & Health ETF (0.02%), Global X Aging Population ETF (0.95%), Sprott Critical Materials ETF (0.45%), Tradr 1X Short Innovation Daily ETF (3.49%), Democratic Large Cap Core ETF (0.80%), Global X Genomics & Biotechnology ETF (0.33%), Tradr 2X Long Innovation ETF (14.07%), Fidelity Metaverse ETF (0.08%), AOT Growth & Innovation ETF (0.11%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks.

Short selling FMED is an investing strategy that aims to generate trading profit from Fidelity Disruptive Medicine ETF as its price is falling. FMED shares are trading up $0.16 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Fidelity Disruptive Medicine ETF occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of FMED, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FMED, twice per month. The most recent reporting period available is July, 15 2025.